Clinical implications of incorporating heterogeneity corrections in mantle field irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 4, 2003, Pages 1135-1142

  Kirsner, Steven M ^a   Kudchadker, Rajat J ^a   Prado, Karl L ^a   Ha, Chul S ^a   Wilder, Richard B ^a   Cox, James D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Heterogeneity corrections; Hodgkin's disease; Mantle irradiation

Indexed keywords

BIOLOGICAL ORGANS; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; IRRADIATION;

HETEROGENITY CORRECTIONS;

RADIOTHERAPY;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; EVALUATION; HEART; HISTOGRAM; HUMAN; LUNG; MANTLE FIELD RADIOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SPINAL CORD; SURFACE PROPERTY; TISSUE DISTRIBUTION; TREATMENT PLANNING;

EID: 0037443430     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04139-1     Document Type: Article

References (14)

1. Cunningham J.R. Tissue inhomogeneity corrections in photon-beam treatment planning. Orton C.G. Progress in medical radiation physics. 1982;103-131 Plenum Press, New York.
2. Role of inhomogeneity corrections in three-dimensional photon treatment planning. Int J Radiat Oncol Biol Phys. 21:1991;59-69.
3. Mackie T.R., Liu H.H., McCullough E.C. Model based photon dose calculation algorithms. Khan F.M., Potish R.A. Treatment planning in radiation oncology. 1998;89-112 Williams and Wilkins Publishing, Baltimore, MD.
4. Butts J.R., Foster A.E. Comparison of commercially available three-dimensional treatment planning algorithms for monitor unit calculations in the presence of heterogeneities. J Appl Clin Med Phys. 2:2001;32-41.
5. Ramsey C.R., Cordrey I.L., Spencer K.M., et al. Dosimetric verification of two commercially available three-dimensional treatment planning systems using the TG 23 test package. Med Phys. 26:1999;1188-1195.
6. McKenna W.G., Yeakel K., Klink A., et al. Is correction for lung density in radiotherapy treatment planning necessary. Int J Radiat Oncol Biol Phys. 13:1987;273-278.
7. Orton C.G., Chungbin S., Klein E.E., et al. Study of lung density corrections in a clinical trial (RTOG 88-08). Int J Radiat Oncol Biol Phys. 41:1998;787-794.
8. Papanikolaou N., Klein E.E. Heterogeneity corrections should be used in treatment planning for lung cancer. Med Phys. 27:2000;1702-1704.
9. Mah K., Van Dyk. On the impact of tissue inhomogeneity corrections in clinical thoracic radiation therapy. Int J Radiat Oncol Biol Phys. 21:1991;1257-1267.
10. Engelsman M., Damen E.M.F., Koken P.W., et al. Impact of simple tissue inhomogeneity correction algorithm on conformal radiotherapy of lung tumors. Radiother Oncol. 60:2001;299-309.
11. Garcia J., Bryant C., Ha C., et al. Three-dimensional treatment planning for central lymphatic irradiation. Med Dosim. 24:1999;295-300.
12. National Comprehensive Cancer Network. Oncology1999;13;78-110.
13. Plowman P.N. Radiotherapy considerations in patients with Hodgkin's disease who receive mediastinal radiotherapy and anthracycline-containing chemotherapy. Clin Oncol. 10:1998;384-391.
14. Schultheiss T.E., Stephens L.C. Permanent radiation myelopathy. Br J Rad. 65:1992;737-753.